Citations

Showing 10 of 108104 citations.

P6037Does the presence of aortopathy in bicuspid aortic valve patients increase the risk of aortopathy in their first degree relatives?
Zuasnabar, A, Bossone, Eduardo , Parma, Gabriel , Florio, Lucía , Body, Simon C. , Dayan, Víctor , BAVCon, Bossone, Eduardo , Citro, Rodolfo , Bellino, Michele , Michelena, Héctor I. , BAVCon

Mayo Clinic

European Heart Journal | December 10, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy566.p6037 Get It

P4450A cardio-metabolic phenotype in carriers of NPPA (rs5086) and NPPB (rs198389) gene variants in the general population: the dominant role of ANP
Fuglestad, Anniken Jørlo , Sangaralingham, S. Jeson , Cannone, Valentina , Burnett, John C. , Fuglestad, A, Sangaralingham, S. Jeson , Scott, Christopher G.

Mayo Clinic

European Heart Journal | December 10, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy563.p4450 Get It

P1264Cardioprotective effects of a novel designer C-type natriuretic peptide-based therapeutic, C53, for the prevention of post-myocardial infarction heart failure
Dzhoyashvili, Nina , CHEN, YING‐SHREN, Harders, Gerald E., Burnett, John C. , Sangaralingham, S. Jeson , Ichiki, Tomoko , Sangaralingham, S. Jeson

Mayo Clinic

European Heart Journal | December 10, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy565.p1264 Get It

P691The clinical course of tuberculous pericarditis in immunocompetent hosts based on serial echocardiography
Kim, M S, Park, S J, Park, S W, Lee, S C, Oh, JS, Kim, Eun‐Kyung , Chang, Sung‐A

Mayo Clinic

European Heart Journal | December 10, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy564.p691 Get It

P5792Risks factors for dofetilide-associated torsades de pointes among hospitalized patients with atrial fibrillation
Naksuk, Niyada , Witt, Christoffer Tobias , Sugrue, Alan , DeSimone, Christopher V. , Witt, C, Kella, Danesh , Noseworthy, Peter A.

Mayo Clinic

European Heart Journal | December 10, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy566.p5792 Get It

2110Risk stratification and clinical outcomes after pulmonary valve replacement
Egbe, Alexander C. , Al-Otaibi, Mohamad , Sharma, Naveen , El‐Harasis, Majd , Sharma, N

Mayo Clinic

European Heart Journal | December 10, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy565.2110 Get It

Dry eye symptoms following blepharoptosis surgery in elderly (≥80 years old) vs. non-elderly patients
Tooley, Andrea A. , Alniemi, Saba T. , Hussain, Ahsen , Hodge, David O. , Bradley, Elizabeth A.

Mayo Clinic

Expert Review of Ophthalmology | December 10, 2018 | Volume: 13 | Issue: 6 | Pages: 373-377

10.1080/17469899.2018.1555033 Get It

Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma
Miller, Kevin C. , Marinelli, John P. , Link, Michael J., Janus, Jeffrey R. , Foote, Robert L. , Price, Katharine A. , García, Joaquín J. , Rivera, Michael , Chintakuntlawar, Ashish V. , Garcia, Joaquin, Chintakuntlawar, Ashish V , Miller, Kevin C , Gompel, Jamie J. Van

Mayo Clinic

Head & Neck | December 10, 2018 | Volume: 41 | Issue: 5 | Pages: 1335-1341

10.1002/hed.25558 | PMID 30536472 Get It

AbstractBackgroundPast research established that surgery plus adjuvant radiotherapy (S + AR) improves overall survival (OS) in esthesioneuroblastoma (ENB). However, it is unknown if the addition of adjuvant chemotherapy (AC) further improves survival. The primary objective of this study was to compare survival among patients treated with S + AR alone to patients who underwent S + AR + AC.MethodsRetrospective review of patient records.ResultsThirty‐eight patients met inclusion criteria for either S + AR or S + AR + AC treatment groups. The S + AR + AC group contained more patients with Kadish stage D disease, dural invasion, and positive histologic margins postsurgery. All S + AR + AC patients received platinum‐based regimens, combined with etoposide in 67%. OS and recurrence‐free survival did not differ between the two groups, even when restricting the analysis to patients with Kadish stages B and C disease.ConclusionPatients who received platinum‐based AC did not exhibit improved survival compared to S + AR alone. Further investigation, preferably prospective, into the optimal use of systemic therapy in ENB is warranted.
Faculty Opinions recommendation of Peripherally derived macrophages modulate microglial function to reduce inflammation after CNS injury.
Bosco, Dale B. , Wu, Long‐Jun

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | December 10, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.734246102.793553667 Get It

Validity and Reliability of a Commercially-Available Velocity and Power Testing Device
Askow, Andrew T. , Stone, Jason D. , Arndts, Daniel J., King, Adam C. , Goto, Shiho , Hannon, Joseph, Garrison, James C. , Bothwell, James M., Esposito, Phil, Jagim, Andrew R. , Jones, Margaret T. , Oliver, Jonathan M. , Jagim, Andrew R , Askow, Andrew T , Jennings, Will

Mayo Clinic

Sports | December 10, 2018 | Volume: 6 | Issue: 4 | Pages: 170

10.3390/sports6040170 | PMID 30544687 Get It

Given the relationship between explosive-type training and power adaptation, tracking movement velocity has become popular. However, unlike previous variables, tracking velocity necessitates the use of a valid and reliable tool to monitor adaptation over time. Therefore, the primary purpose of this research was to assess the validity and reliability of a commercially-available linear position transducer (LPT). Nine resistance-trained men completed four sessions consisting of a single set of barbell back squat to volitional failure at 75% or 90% one-repetition maximum. Kinetic and kinematic data were captured for each repetition by the LPT and a 3-dimensional motion capture system and bipedal force platforms. In total, 357 instances of data from both systems were analyzed using intraclass correlations (ICC), effect size estimates, and standard error of measurement. Overall, the LPT yielded excellent ICCs (all ≥0.94) and small/trivial differences (d < 0.60). When categorized by median values, ICCs remained high (all ≥0.89) and differences remained small or trivial with the exception of high peak velocities (d = −1.46). Together, these data indicate that the commercially-available LPT is a valid and reliable measure for kinetic and kinematic variables of interest with the exception of high peak velocities.